What Abbott’s Big FDA Approval Means for the Tricuspid Device Market

TriClip leverages the same clip-based technology as Abbott's MitraClip device, which is designed to treat leaky mitral valves (mitral regurgitation), but the company specifically designed TriClip to treat the tricuspid valve's complex anatomy. This approval comes just two months after FDA approved Edwards Lifesciences’ Evoque transcatheter tricuspid valve replacement (TTVR) for the treatment of eligible patients with TR.